Who
Susan D. Wyrick
Officer
Company insider
Files Form 4 as: Officer, Sana Biotechnology; Pao, Achieve Life Sciences.
In numbers
- Trades disclosed
- 69
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $5,640
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 12 Mar 2013
- Last trade
- 9 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code F | $10K3,342 at $3.13 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code F | $3,2401,045 at $3.10 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code F | $10K3,342 at $3.13 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code F | $3,2401,045 at $3.10 | filing |
| 7 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code M | —3,250 at $0.00 | filing |
| 7 Mar 2026filed 10 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,250 at $0.00 | filing |
| 7 Mar 2026filed 10 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,250 at $0.00 | filing |
| 7 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code M | —3,250 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code M | —10,416 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,416 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,416 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code M | —10,416 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,833 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —206,250 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,833 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —206,250 at $0.00 | filing |
| 3 Mar 2026filed 4 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code F | $1,920491 at $3.91 | filing |
| 3 Mar 2026filed 4 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code F | $1,920491 at $3.91 | filing |
| 2 Mar 2026filed 4 Mar 2026 | SANA Sana BiotechnologyBiotechnology | SEC FORM 4 Code M | —1,525 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | SANA Sana Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,525 at $0.00 | filing |
News
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026ACHV · manilatimes.net · 21 Oct 2026
0 headlines in the last 90 days name Susan D. Wyrick; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.